Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defactinib and Avutometinib +/- Encorafenib in Melanoma Brain Metastases
NCT06194929Phase 2Recruiting
- Sponsor
- University of Utah
- Start
- Mar 2024
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of defactinib, avutometinib in cutaneous melanoma (CM), brain metastases, sponsored by University of Utah. Started Mar 2024; status: recruiting.
02
Drugs
defactinibavutometinib
03
Conditions
cutaneous melanoma (CM)brain metastases
Beyond the preview
Go deeper on NCT06194929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06194929.